CYLD and melanoma: Bosserhoff and colleagues showed that a homozygous loss of CYLD led to a shortened latency in melanoma development and progression in our Grm1-driven spontaneous melanoma mouse model Tg(Grm1)EPv, as well as increased vasculogenic mimicry and lymph angiogenesis [59].